Beurs gesloten -
Nasdaq
22:00:00 25-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
24,25
USD
|
-2,34%
|
|
+4,66%
|
-10,91%
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
4.611
|
5.327
|
2.692
|
2.159
|
1.914
|
-
|
-
|
Bedrijfswaarde
1 |
4.318
|
4.367
|
1.613
|
969,4
|
1.127
|
1.537
|
1.914
|
K/w-verhouding
|
-19,5
x
|
-13,8
x
|
-9,47
x
|
-15,8
x
|
-5,13
x
|
-5,14
x
|
-5,15
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
192.105
x
|
103
x
|
44,2
x
|
5,72
x
|
38,2
x
|
36,8
x
|
32,2
x
|
Bedrijfswaarde/omzet
|
179.928
x
|
84,2
x
|
26,5
x
|
2,57
x
|
22,5
x
|
29,5
x
|
32,2
x
|
Bedrijfswaarde/EBITDA
|
-
|
-11,3
x
|
-4,97
x
|
-6,2
x
|
-2,78
x
|
-3,55
x
|
-4,18
x
|
Bedrijfswaarde/FCF
|
-38,5
x
|
-38,6
x
|
-61,1
x
|
-5,3
x
|
-2,95
x
|
-4,14
x
|
-5,87
x
|
FCF Yield
|
-2,6%
|
-2,59%
|
-1,64%
|
-18,9%
|
-33,9%
|
-24,2%
|
-17%
|
Price to Book
|
15,5
x
|
6,19
x
|
3,66
x
|
2,14
x
|
2,28
x
|
2,73
x
|
-
|
Aantal aandelen (in duizenden)
|
56.474
|
66.849
|
68.821
|
79.326
|
78.909
|
-
|
-
|
Referentieprijs
2 |
81,64
|
79,69
|
39,11
|
27,22
|
24,25
|
24,25
|
24,25
|
Datum van publicatie
|
15/03/21
|
28/02/22
|
28/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
0,018
|
0,024
|
51,84
|
60,92
|
377,7
|
50,11
|
52,04
|
59,41
|
EBITDA
1 |
-
|
-
|
-385
|
-324,3
|
-156,5
|
-405,1
|
-432,6
|
-457,3
|
Bedrijfsresultaat (EBIT)
1 |
-75,15
|
-132,8
|
-392,5
|
-338,5
|
-176,5
|
-423,3
|
-449,4
|
-482,6
|
Operationele Marge
|
-417.522,22%
|
-553.166,67%
|
-757,01%
|
-555,61%
|
-46,73%
|
-844,72%
|
-863,64%
|
-812,44%
|
Resultaat voor belastingen (EBT)
1 |
-78,33
|
-194,6
|
-370,6
|
-260,2
|
-131,2
|
-401,5
|
-430,9
|
-461,2
|
Nettowinst (verlies)
1 |
-91,04
|
-195,9
|
-370,6
|
-289,1
|
-132,5
|
-402,1
|
-432,1
|
-454,4
|
Nettomarge
|
-505.777,78%
|
-816.120,83%
|
-714,91%
|
-474,54%
|
-35,09%
|
-802,45%
|
-830,38%
|
-764,97%
|
WPA
2 |
-2,489
|
-4,190
|
-5,770
|
-4,130
|
-1,720
|
-4,728
|
-4,722
|
-4,712
|
Free Cash Flow
1 |
-84,52
|
-112,1
|
-113,1
|
-26,42
|
-182,9
|
-382,6
|
-371,5
|
-326
|
FCF-marge
|
-469.561,11%
|
-467.075%
|
-218,11%
|
-43,37%
|
-48,43%
|
-763,43%
|
-713,96%
|
-548,83%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
30/03/20
|
15/03/21
|
28/02/22
|
28/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Omzet
1 |
51,07
|
8,432
|
16,65
|
15,8
|
20,04
|
24,21
|
20,12
|
17,19
|
316,2
|
7,41
|
12,41
|
12,87
|
13,73
|
10
|
10
|
EBITDA
1 |
-60,85
|
-72,91
|
-
|
-87,83
|
-85,04
|
-
|
-97,33
|
-103,1
|
138,2
|
-98,7
|
-90,71
|
-97,34
|
-102,9
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-63,48
|
-76,22
|
-81,97
|
-91,3
|
-88,98
|
-98,93
|
-102,1
|
-108,3
|
132,9
|
-104,1
|
-101,8
|
-103,7
|
-117,9
|
-115
|
-120
|
Operationele Marge
|
-124,31%
|
-904%
|
-492,23%
|
-577,9%
|
-444,1%
|
-408,66%
|
-507,79%
|
-629,72%
|
42,02%
|
-1.405,29%
|
-819,92%
|
-806,2%
|
-858,88%
|
-1.150%
|
-1.200%
|
Resultaat voor belastingen (EBT)
1 |
-64,71
|
-69,21
|
-71,95
|
-81,66
|
-37,35
|
-96,46
|
-82,78
|
-96,09
|
144,2
|
-98,67
|
-94,02
|
-96,87
|
-112,1
|
-114
|
-119
|
Nettowinst (verlies)
1 |
-64,71
|
-69,21
|
-71,95
|
-109,6
|
-38,35
|
-96,46
|
-82,78
|
-96,09
|
142,8
|
-98,67
|
-94,8
|
-97,37
|
-111,4
|
-114
|
-119
|
Nettomarge
|
-126,71%
|
-820,85%
|
-432,08%
|
-693,56%
|
-191,39%
|
-398,46%
|
-411,49%
|
-558,88%
|
45,16%
|
-1.331,57%
|
-763,63%
|
-756,59%
|
-811,39%
|
-1.140%
|
-1.190%
|
WPA
2 |
-0,9500
|
-1,010
|
-1,020
|
-1,560
|
-0,5400
|
-1,330
|
-1,080
|
-1,220
|
1,730
|
-1,210
|
-1,129
|
-1,147
|
-1,260
|
-1,172
|
-1,185
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
28/02/22
|
9/05/22
|
9/08/22
|
7/11/22
|
28/02/23
|
10/05/23
|
8/08/23
|
8/11/23
|
27/02/24
|
7/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
-
|
292
|
960
|
1.078
|
1.190
|
786
|
376
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-84,5
|
-112
|
-113
|
-26,4
|
-183
|
-383
|
-372
|
-326
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-881%
|
-69,1%
|
-37,1%
|
-15,5%
|
-50%
|
-68,6%
|
-80,3%
|
ROA (netto-inkomsten/totale activa)
|
-56,4%
|
-64,5%
|
-38,5%
|
-20,5%
|
-11,7%
|
-30,3%
|
-35,8%
|
-
|
Totale activa
1 |
161,6
|
303,9
|
963,1
|
1.408
|
1.134
|
1.326
|
1.208
|
-
|
Nettoactief per aandeel
2 |
-3,920
|
5,250
|
12,90
|
10,70
|
12,70
|
10,70
|
8,870
|
-
|
Cashflow per aandeel
2 |
-
|
-
|
-1,030
|
0,3200
|
-1,930
|
-3,830
|
-3,560
|
-
|
Capex
1 |
12,5
|
16,4
|
46,8
|
49
|
33,7
|
29,7
|
31,2
|
30,6
|
Capex/omzet
|
69.544,44%
|
68.154,17%
|
90,29%
|
80,35%
|
8,93%
|
59,2%
|
59,96%
|
51,57%
|
Datum van publicatie
|
30/03/20
|
15/03/21
|
28/02/22
|
28/02/23
|
27/02/24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
24,25
USD Gemiddelde koersdoel
48,38
USD Spread / Gemiddelde doel +99,52% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -10,91% | 1,91 mld. | | +38,36% | 52,73 mld. | | +39,07% | 39 mld. | | -8,63% | 38,52 mld. | | +25,46% | 30,38 mld. | | -11,17% | 26,39 mld. | | +11,44% | 26,08 mld. | | +45,09% | 14,15 mld. | | +32,93% | 12,6 mld. | | -5,30% | 11,51 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|